News

MX Labs raises $2 million to put personalised health diagnostics in your pocket

reach52 kickstarts campaigns with Sanofi in Cambodia for people at risk of diabetes and hypertension, enrolling high-risk individuals into patient program

The LungPass Pro device is now registered as an FDA-exempt device, allowing US sales (to medical professionals) to commence!

reach52 featured in a case study in report "The Case for Digital Health: Accelerating Progress to Achieve UHC" by Transform Health

reach52's CEO wrote on the challenges and actions needed to overcome the frontline heath worker shortage and to achieve universal health coverage

RetiSpec was mentioned in Zoomer's article focusing on early detection of Alzheimer's to cure dementia